Centaurus Financial’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43M | Sell |
11,874
-19,825
| -63% | -$2.29M | 0.07% | 262 |
|
|
2025
Q4 | $3.34M | Buy |
31,699
+6,741
| +27% | +$633K | 0.15% | 140 |
|
|
2025
Q3 | $2.1M | Buy |
24,958
+1,371
| +6% | +$113K | 0.1% | 196 |
|
|
2025
Q2 | $1.87M | Sell |
23,587
-119
| -0.5% | -$9.46K | 0.11% | 196 |
|
|
2025
Q1 | $2.13M | Buy |
23,706
+12,800
| +117% | +$1.2M | 0.13% | 160 |
|
|
2024
Q4 | $1.08M | Sell |
10,906
-1,743
| -14% | -$180K | 0.07% | 262 |
|
|
2024
Q3 | $1.44M | Sell |
12,649
-229
| -2% | -$27.2K | 0.09% | 204 |
|
|
2024
Q2 | $1.59M | Buy |
12,878
+178
| +1% | +$22.9K | 0.11% | 176 |
|
|
2024
Q1 | $1.68M | Sell |
12,700
-231
| -2% | -$28.5K | 0.12% | 170 |
|
|
2023
Q4 | $1.41M | Sell |
12,931
-417
| -3% | -$43.3K | 0.11% | 183 |
|
|
2023
Q3 | $1.37M | Sell |
13,348
-1,156
| -8% | -$125K | 0.12% | 176 |
|
|
2023
Q2 | $1.67M | Sell |
14,504
-5,510
| -28% | -$626K | 0.15% | 159 |
|
|
2023
Q1 | $2.13M | Buy |
20,014
+2,092
| +12% | +$226K | 0.17% | 146 |
|
|
2022
Q4 | $1.99M | Sell |
17,922
-106
| -0.6% | -$10.8K | 0.19% | 136 |
|
|
2022
Q3 | $1.55M | Buy |
18,028
+296
| +2% | +$26.4K | 0.15% | 163 |
|
|
2022
Q2 | $1.62M | Buy |
17,732
+2,229
| +14% | +$198K | 0.16% | 163 |
|
|
2022
Q1 | $1.27M | Buy |
15,503
+680
| +5% | +$53.6K | 0.1% | 240 |
|
|
2021
Q4 | $1.14M | Buy |
14,823
+688
| +5% | +$54.8K | 0.09% | 252 |
|
|
2021
Q3 | $1.06M | Buy |
14,135
+1,222
| +9% | +$92.9K | 0.09% | 260 |
|
|
2021
Q2 | $1M | Buy |
12,913
+510
| +4% | +$37.9K | 0.08% | 275 |
|
|
2021
Q1 | $912K | Sell |
12,403
-465
| -4% | -$34.3K | 0.09% | 251 |
|
|
2020
Q4 | $1M | Sell |
12,868
-1,001
| -7% | -$76.6K | 0.11% | 234 |
|
|
2020
Q3 | $1.1M | Buy |
13,869
+1,442
| +12% | +$113K | 0.15% | 156 |
|
|
2020
Q2 | $917K | Sell |
12,427
-89
| -0.7% | -$6.7K | 0.14% | 180 |
|
|
2020
Q1 | $919K | Buy |
12,516
+6,927
| +124% | +$544K | 0.18% | 140 |
|
|
2019
Q4 | $485K | Buy |
+5,589
| New | +$459K | 0.07% | 312 |
|
|
2019
Q3 | – | Sell |
-2,400
| Closed | -$192K | – | 533 |
|
|
2019
Q2 | $192K | Buy |
2,400
+2,204
| +1,124% | +$169K | 0.03% | 434 |
|
|
2019
Q1 | $2.25K | Buy |
196
+35
| +22% | +$2.62K | 0.01% | 466 |
|
|
2018
Q4 | $2 | Buy |
161
+159
| +7,950% | +$11.2K | 0.01% | 414 |
|
|
2018
Q3 | $145 | Sell |
2
-12,398
| -100% | -$790K | 0.03% | 443 |
|
|
2018
Q2 | $718K | Buy |
+12,400
| New | +$700K | 0.1% | 218 |
|
Other funds holding MRK
VCM
VPM
Centaurus Financial's MRK Position: Q1 2026 in Review
Centaurus Financial reduced its Merck (MRK) stake by 63% in Q1 2026, selling an estimated $2.29M and leaving 11,874 shares worth $1.43M. The position accounts for 0.07% of the portfolio, ranked #262.
Centaurus Financial first reported a position in MRK in Q2 2018 and has held it in 31 quarters since. The position peaked at $3.34M in Q4 2025. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Centaurus Financial held 11,874 shares of Merck worth $1.43M as of Q1 2026.
- Centaurus Financial sold 19,825 Merck shares in Q1 2026, an estimated $2.29M.
- Merck made up 0.07% of Centaurus Financial's portfolio in Q1 2026, its #262 holding.
- Centaurus Financial first reported a position in Merck in Q2 2018 and has held it in 31 quarters since.
- Centaurus Financial's Merck position peaked at $3.34M in Q4 2025.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.